Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Ketamine vs Morphine for Sickle Cell Crisis Pain
NCT02434939Phase 4Completed
- Sponsor
- Makerere University
- Start
- Jun 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in sickle cell disease (SCD), sponsored by Makerere University. Started Jun 2015; status: completed.
02
Drugs
ketamine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02434939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434939.